J. L. Ross Anderson
University of Bristol
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J. L. Ross Anderson.
Nature Chemical Biology | 2013
Tammer A. Farid; Goutham Kodali; Lee A. Solomon; Bruce R. Lichtenstein; Molly M. Sheehan; Bryan A. Fry; Chris Bialas; Nathan M. Ennist; Jessica A Siedlecki; Zhenyu Zhao; Matthew A. Stetz; Kathleen G. Valentine; J. L. Ross Anderson; A. Joshua Wand; Bohdana M. Discher; Christopher C. Moser; P. Leslie Dutton
Emulating functions of natural enzymes in man-made constructs has proven challenging. Here we describe a man-made protein platform that reproduces many of the diverse functions of natural oxidoreductases without importing the complex and obscure interactions common to natural proteins. Our design is founded on an elementary, structurally stable 4-α-helix protein monomer with a minimalist interior malleable enough to accommodate various light- and redox-active cofactors and with an exterior tolerating extensive charge patterning for modulation of redox cofactor potentials and environmental interactions. Despite its modest size, the construct offers several independent domains for functional engineering that targets diverse natural activities, including dioxygen binding and superoxide and peroxide generation, interprotein electron transfer to natural cytochrome c and light-activated intraprotein energy transfer and charge separation approximating the core reactions of photosynthesis, cryptochrome and photolyase. The highly stable, readily expressible and biocompatible characteristics of these open-ended designs promise development of practical in vitro and in vivo applications.
Chemical Science | 2011
Mei Li; David C. Green; J. L. Ross Anderson; Bernard P. Binks; Stephen Mann
Silica nanoparticles with a balance of hydrophilic and hydrophobic surface properties exhibit surfactant-like behaviour, and as a consequence can strongly adsorb at oil/water interfaces to stabilize the formation of water micro-droplets. Here we exploit this strategy to construct a model of a primitive bio-inorganic protocell, which unlike conventional paradigms based on self-assembled vesicles, is structurally delineated by a porous inorganic membrane rather than a lipid-based bilayer. As proof-of-principle we show that the nanoparticle-stabilized droplets (colloidosomes) can support a range of functionally active biomolecules and bio-machinery related to metabolic and informational processing. Specifically, we demonstrate that the rate of cell-free in vitrogene expression of enhanced green fluorescent protein (eGFP) is essentially the same within the colloidosome interior as in bulk aqueous solution. In addition, we report considerable enhancements in the specific activity of enzymes such as lipoprotein lipase, chymotrypsin or alkaline phosphatase when entrapped within the nanoparticle-stabilized water droplets. Our results suggest that artificial protocells based on the construction of biological/inorganic nanoscale components could have considerable potential in areas such as synthetic biology and bionanotechnology. In a wider perspective, studies on bio-inorganic protocells could provide alternative models for evaluating potential prebiotic pathways prior to the emergence of lipid-based compartmentalization on the early Earth.
Biochemical Society Transactions | 2012
Bruce R. Lichtenstein; Tammer A. Farid; Goutham Kodali; Lee A. Solomon; J. L. Ross Anderson; Molly M. Sheehan; Nathan M. Ennist; Bryan A. Fry; Sarah E. Chobot; Chris Bialas; Joshua A. Mancini; Craig T. Armstrong; Zhenyu Zhao; Tatiana V. Esipova; David Snell; Sergei A. Vinogradov; Bohdana M. Discher; Christopher C. Moser; P. Leslie Dutton
The study of natural enzymes is complicated by the fact that only the most recent evolutionary progression can be observed. In particular, natural oxidoreductases stand out as profoundly complex proteins in which the molecular roots of function, structure and biological integration are collectively intertwined and individually obscured. In the present paper, we describe our experimental approach that removes many of these often bewildering complexities to identify in simple terms the necessary and sufficient requirements for oxidoreductase function. Ours is a synthetic biology approach that focuses on from-scratch construction of protein maquettes designed principally to promote or suppress biologically relevant oxidations and reductions. The approach avoids mimicry and divorces the commonly made and almost certainly false ascription of atomistically detailed functionally unique roles to a particular protein primary sequence, to gain a new freedom to explore protein-based enzyme function. Maquette design and construction methods make use of iterative steps, retraceable when necessary, to successfully develop a protein family of sturdy and versatile single-chain three- and four-α-helical structural platforms readily expressible in bacteria. Internally, they prove malleable enough to incorporate in prescribed positions most natural redox cofactors and many more simplified synthetic analogues. External polarity, charge-patterning and chemical linkers direct maquettes to functional assembly in membranes, on nanostructured titania, and to organize on selected planar surfaces and materials. These protein maquettes engage in light harvesting and energy transfer, in photochemical charge separation and electron transfer, in stable dioxygen binding and in simple oxidative chemistry that is the basis of multi-electron oxidative and reductive catalysis.
Nature Communications | 2015
James P. K. Armstrong; Rameen Shakur; Joseph P. Horne; Sally C. Dickinson; Craig T. Armstrong; Katherine Lau; Juned Kadiwala; Robert Lowe; Annela M. Seddon; Stephen Mann; J. L. Ross Anderson; Adam W. Perriman; Anthony P. Hollander
Restricted oxygen diffusion can result in central cell necrosis in engineered tissue, a problem that is exacerbated when engineering large tissue constructs for clinical application. Here we show that pre-treating human mesenchymal stem cells (hMSCs) with synthetic membrane-active myoglobin-polymer–surfactant complexes can provide a reservoir of oxygen capable of alleviating necrosis at the centre of hyaline cartilage. This is achieved through the development of a new cell functionalization methodology based on polymer–surfactant conjugation, which allows the delivery of functional proteins to the hMSC membrane. This new approach circumvents the need for cell surface engineering using protein chimerization or genetic transfection, and we demonstrate that the surface-modified hMSCs retain their ability to proliferate and to undergo multilineage differentiation. The functionalization technology is facile, versatile and non-disruptive, and in addition to tissue oxygenation, it should have far-reaching application in a host of tissue engineering and cell-based therapies.
Current Opinion in Chemical Biology | 2014
Daniel W. Watkins; Craig T. Armstrong; J. L. Ross Anderson
Manmade protein design is founded on the concept that a protein with minimal evolutionary complexity is a viable scaffold for incorporating simple engineering elements responsible for function in natural proteins and enzymes. There has been significant, recent success both in fabricating manmade protein components that exhibit functional elements inspired by natural oxidoreductases, and the functional integration of this componentry with natural proteins and biochemical pathways. Here we discuss the state of the art in de novo oxidoreductase construction, focusing on the diverse manmade componentry available and how their functions might be interfaced and integrated within living organisms.
Biochemical Journal | 2014
Craig T. Armstrong; J. L. Ross Anderson; Richard M. Denton
The regulation of the 2-oxoglutarate dehydrogenase complex is central to intramitochondrial energy metabolism. In the present study, the active full-length E1 subunit of the human complex has been expressed and shown to be regulated by Ca2+, adenine nucleotides and NADH, with NADH exerting a major influence on the K0.5 value for Ca2+. We investigated two potential Ca2+-binding sites on E1, which we term site 1 (D114ADLD) and site 2 (E139SDLD). Comparison of sequences from vertebrates with those from Ca2+-insensitive non-vertebrate complexes suggest that site 1 may be the more important. Consistent with this view, a mutated form of E1, D114A, shows a 6-fold decrease in sensitivity for Ca2+, whereas variant ∆site1 (in which the sequence of site 1 is replaced by A114AALA) exhibits an almost complete loss of Ca2+ activation. Variant ∆site2 (in which the sequence is replaced with A139SALA) shows no measurable change in Ca2+ sensitivity. We conclude that site 1, but not site 2, forms part of a regulatory Ca2+-binding site, which is distinct from other previously described Ca2+-binding sites.
Nature Communications | 2017
Daniel W. Watkins; Jonathan M. X. Jenkins; Katie J. Grayson; Nicola Wood; Jack W. Steventon; Kristian K. Le Vay; Matthew I. Goodwin; Anna Mullen; Henry J. Bailey; Matthew P. Crump; Fraser MacMillan; Adrian J. Mulholland; Gus Cameron; Richard B. Sessions; Stephen Mann; J. L. Ross Anderson
Although catalytic mechanisms in natural enzymes are well understood, achieving the diverse palette of reaction chemistries in re-engineered native proteins has proved challenging. Wholesale modification of natural enzymes is potentially compromised by their intrinsic complexity, which often obscures the underlying principles governing biocatalytic efficiency. The maquette approach can circumvent this complexity by combining a robust de novo designed chassis with a design process that avoids atomistic mimicry of natural proteins. Here, we apply this method to the construction of a highly efficient, promiscuous, and thermostable artificial enzyme that catalyzes a diverse array of substrate oxidations coupled to the reduction of H2O2. The maquette exhibits kinetics that match and even surpass those of certain natural peroxidases, retains its activity at elevated temperature and in the presence of organic solvents, and provides a simple platform for interrogating catalytic intermediates common to natural heme-containing enzymes.Catalytic mechanisms of enzymes are well understood, but achieving diverse reaction chemistries in re-engineered proteins can be difficult. Here the authors show a highly efficient and thermostable artificial enzyme that catalyzes a diverse array of substrate oxidations coupled to the reduction of H2O2.
Current Opinion in Structural Biology | 2018
Katie J. Grayson; J. L. Ross Anderson
Highlights • Here we highlight our recent advances in de novo enzyme design.• Heme C-binding maquettes with minimal complexity serve as promiscuous and efficient enzymes.• Well-defined substrate binding sites are possibly not required for efficient oxidoreductase catalysis.
ACS Synthetic Biology | 2017
T-Y Dora Tang; Dario Cecchi; Giorgio Fracasso; Davide Accardi; Angelique Coutable-Pennarun; Sheref S. Mansy; Adam W. Perriman; J. L. Ross Anderson; Stephen Mann
A gene-directed chemical communication pathway between synthetic protocell signaling transmitters (lipid vesicles) and receivers (proteinosomes) was designed, built and tested using a bottom-up modular approach comprising small molecule transcriptional control, cell-free gene expression, porin-directed efflux, substrate signaling, and enzyme cascade-mediated processing.
Scientific Reports | 2018
Christophe J. Lalaurie; Virginie N J Dufour; Anna Meletiou; Sarah Ratcliffe; Abigail Harland; Olivia Wilson; Chiratchaya Vamasiri; Deborah K. Shoemark; Christopher Williams; Christopher J. Arthur; Richard B. Sessions; Matthew P. Crump; J. L. Ross Anderson; Paul Curnow
The de novo design of integral membrane proteins remains a major challenge in protein chemistry. Here, we describe the bottom-up design of a genetically-encoded synthetic membrane protein comprising only four amino acids (L, S, G and W) in the transmembrane domains. This artificial sequence, which we call REAMP for recombinantly expressed artificial membrane protein, is a single chain of 133 residues arranged into four antiparallel membrane-spanning α-helices. REAMP was overexpressed in Escherichia coli and localized to the cytoplasmic membrane with the intended transmembrane topology. Recombinant REAMP could be extracted from the cell membrane in detergent micelles and was robust and stable in vitro, containing helical secondary structure consistent with the original design. Engineered mono- and bis-histidine residues in the membrane domain of REAMP were able to coordinate heme in vitro, in a manner reminiscent of natural b-type cytochromes. This binding shifted the electrochemical potential of the cofactor, producing a synthetic hemoprotein capable of nascent redox catalysis. These results show that a highly reduced set of amino acids is sufficient to mimic some key properties of natural proteins, and that cellular biosynthesis is a viable route for the production of minimal de novo membrane sequences.